CHRISTOPHER BUSAPAVANIJ: Open Payments
NPI 1952589814 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,212 in 95 payments from 19 companies in 2025. Trend: 2023 $1,212 · 2024 $1,009 · 2025 $2,212
Food & beverage: $2,212
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 13 | $306 |
| Janssen Biotech, Inc. | 14 | $296 |
| PFIZER INC. | 12 | $214 |
| Novartis Pharmaceuticals Corporation | 6 | $157 |
| Lilly USA, LLC | 5 | $140 |
| ABBVIE INC. | 6 | $135 |
| Organon LLC | 6 | $126 |
| UCB, Inc. | 5 | $118 |
| Arcutis Biotherapeutics, Inc. | 5 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
Products named: OPZELURA, TREMFYA, CIBINQO, COSENTYX, Bimzelx, DUPIXENT, Zoryve, Sotyktu.
Industry payments across NY — which companies pay providers there.
